Compare KRYS & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRYS | ESNT |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 5.9B |
| IPO Year | 2017 | 2013 |
| Metric | KRYS | ESNT |
|---|---|---|
| Price | $257.21 | $58.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $297.60 | $67.86 |
| AVG Volume (30 Days) | 219.9K | ★ 691.8K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | ★ 128.00 | 0.73 |
| EPS | 6.84 | ★ 6.90 |
| Revenue | $389,130,000.00 | ★ $1,260,935,000.00 |
| Revenue This Year | $40.88 | N/A |
| Revenue Next Year | $35.16 | $3.27 |
| P/E Ratio | $36.75 | ★ $8.39 |
| Revenue Growth | ★ 33.94 | 1.45 |
| 52 Week Low | $123.03 | $51.61 |
| 52 Week High | $298.30 | $67.09 |
| Indicator | KRYS | ESNT |
|---|---|---|
| Relative Strength Index (RSI) | 46.84 | 38.27 |
| Support Level | $251.93 | $56.84 |
| Resistance Level | $293.60 | $61.99 |
| Average True Range (ATR) | 9.21 | 1.09 |
| MACD | -0.66 | -0.04 |
| Stochastic Oscillator | 48.32 | 26.33 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.